Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-001829
Filing Date
2023-02-23
Accepted
2023-02-23 07:30:49
Documents
96
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acrs-20221231x10k.htm   iXBRL 10-K 2722090
2 EX-10.12 acrs-20221231xex10d12.htm EX-10.12 16765
3 EX-10.16 acrs-20221231xex10d16.htm EX-10.16 25551
4 EX-10.18 acrs-20221231xex10d18.htm EX-10.18 134491
5 EX-10.19 acrs-20221231xex10d19.htm EX-10.19 84880
6 EX-10.23 acrs-20221231xex10d23.htm EX-10.23 117867
7 EX-10.24 acrs-20221231xex10d24.htm EX-10.24 120332
8 EX-21.1 acrs-20221231xex21d1.htm EX-21.1 6502
9 EX-23.1 acrs-20221231xex23d1.htm EX-23.1 2755
10 EX-31.1 acrs-20221231xex31d1.htm EX-31.1 9681
11 EX-31.2 acrs-20221231xex31d2.htm EX-31.2 9768
12 EX-32.1 acrs-20221231xex32d1.htm EX-32.1 9257
13 GRAPHIC acrs-20221231x10k002.jpg GRAPHIC 36554
14 GRAPHIC acrs-20221231xex10d16001.jpg GRAPHIC 11372
15 GRAPHIC acrs-20221231xex10d18001.jpg GRAPHIC 11372
16 GRAPHIC acrs-20221231xex10d19002.jpg GRAPHIC 939
17 GRAPHIC acrs-20221231xex10d23002.jpg GRAPHIC 797
18 GRAPHIC acrs-20221231xex10d24002.jpg GRAPHIC 795
  Complete submission text file 0001558370-23-001829.txt   11464268

Data Files

Seq Description Document Type Size
19 EX-101.SCH acrs-20221231.xsd EX-101.SCH 55477
20 EX-101.CAL acrs-20221231_cal.xml EX-101.CAL 73018
21 EX-101.DEF acrs-20221231_def.xml EX-101.DEF 249031
22 EX-101.LAB acrs-20221231_lab.xml EX-101.LAB 609734
23 EX-101.PRE acrs-20221231_pre.xml EX-101.PRE 424187
90 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20221231x10k_htm.xml XML 2115210
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37581 | Film No.: 23655936
SIC: 2834 Pharmaceutical Preparations